Viraj Tyagi
Global Alliance Leader, Precision Medicine & Diagnostics Johnson & Johnson Innovative Medicine
Viraj Tyagi is a Global Alliance Leader of Oncology Precision Medicine & Diagnostics at Johnson & Johnson, where he leads the partnering team that drive collaborations, governance, and tools to advance J&Js extensive oncology portfolio. Prior to joining J&J in 2024, Viraj held leadership roles at Alnylam (Senior Director – Business Strategy & Operations) where he led several critical organizational capability-building initiatives, at Takeda (Director of Partnerships) where he helped establish the partnership office and write the partnering playbook while leading Cell & Gene Therapy Alliances, and Novartis where he spent almost a decade in a variety of roles spanning Business development and Portfolio Management. The opportunity for strategic & mutual benefit between two organizations that leads to better and faster therapies for patients that are waiting is what drives him.
Seminars
- Exploring Johnson & Johnson’s Pharma–Diagnostics Partnership Model: An overview of how J&J structures and enables early, aligned collaboration between drug and diagnostics teams and external partners to support integrated decision making, development strategies, and regulatory readiness
- Showcasing Insights from Successful Precision Oncology Programs: Learnings drawn from delivering CDx-enabled oncology programs, highlighting the partnership approaches that help translate scientific innovation into meaningful real-world impact
- Looking Ahead – How Precision Medicine Partnerships are Evolving Across the Industry: A broader perspective on where pharma-diagnostics partnering is headed, and key considerations for delivering CDx-enabled therapies at scale across patients, clinicians and health systems